140 results on '"Valdiglesias, V."'
Search Results
2. The Application, Neurotoxicity, and Related Mechanism of Iron Oxide Nanoparticles
- Author
-
Kiliç, G., primary, Fernández-Bertólez, N., additional, Costa, C., additional, Brandão, F., additional, Teixeira, J.P., additional, Pásaro, E., additional, Laffon, B., additional, and Valdiglesias, V., additional
- Published
- 2017
- Full Text
- View/download PDF
3. List of Contributors
- Author
-
Brandão, F., primary, Chen, H., additional, Costa, C., additional, Fernández-Bertólez, N., additional, Flora, S.J.S., additional, Gao, F., additional, Gao, H., additional, Gao, X., additional, Gu, X., additional, He, M., additional, He, Q., additional, Ikeda, K., additional, Jiang, X., additional, Ju, D., additional, Kiliç, G., additional, Laffon, B., additional, Li, J., additional, Liu, Y., additional, Li, Y., additional, Lou, K., additional, Manome, Y., additional, Martin, F.L., additional, Mi, G., additional, Pásaro, E., additional, Shao, L.Q., additional, Shi, D., additional, Song, B., additional, Strużyńska, L., additional, Tachibana, T., additional, Teixeira, J.P., additional, Valdiglesias, V., additional, Webster, T.J., additional, and Zhong, C., additional
- Published
- 2017
- Full Text
- View/download PDF
4. Okadaic Acid
- Author
-
Valdiglesias, V., primary, Laffon, B., additional, Fernández-Tajes, J., additional, and Méndez, J., additional
- Published
- 2014
- Full Text
- View/download PDF
5. Moving Towards Common Data Elements and Core Outcome Measures in Frailty Research
- Author
-
Muscedere, J, Afilalo, J, de Carvalho, IA, Cesari, M, Clegg, A, Eriksen, HE, Evans, KR, Heckman, G, Hirdes, JP, Kim, PM, Laffon, B, Lynn, J, Martin, F, Prorok, JC, Rockwood, K, Manas, LR, Rolfson, D, Shaw, G, Shea, B, Sinha, S, Theou, O, Tugwell, P, Valdiglesias, V, Vellas, B, Veronese, N, Wallace, LMK, Williamson, PR, and Canadian Frailty Network
- Subjects
education - Abstract
With aging populations around the world, frailty is becoming more prevalent increasing the need for health systems and social systems to deliver optimal evidence based care. However, in spite of the growing number of frailty publications, high-quality evidence for decision making is often lacking. Inadequate descriptions of the populations enrolled including frailty severity and frailty conceptualization, lack of use of validated frailty assessment tools, utilization of different frailty instruments between studies, and variation in reported outcomes impairs the ability to interpret, generalize and implement the research findings. The utilization of common data elements (CDEs) and core outcome measures (COMs) in clinical trials is increasingly being adopted to address such concerns. To catalyze the development and use of CDEs and COMs for future frailty studies, the Canadian Frailty Network (http://www.cfn-nce.ca; CFN), a not-for-profit pan-Canadian nationally-funded research network, convened an international group of experts to examine the issue and plan the path forward. The meeting was structured to allow for an examination of current frailty evidence, ability to learn from other COMs and CDEs initiatives, discussions about specific considerations for frailty COMs and CDEs and finally the identification of the necessary steps for a COMs and CDEs consensus initiative going forward. It was agreed at the onset of the meeting that a statement based on the meeting would be published and herein we report the statement.
- Published
- 2020
6. MOVING TOWARDS COMMON DATA ELEMENTS AND CORE OUTCOME MEASURES IN FRAILTY RESEARCH
- Author
-
Muscedere, J., primary, Afilalo, J., additional, Araujo de Carvalho, I., additional, Cesari, M., additional, Clegg, A., additional, Eriksen, H.E., additional, Evans, K.R., additional, Heckman, G., additional, Hirdes, J.P., additional, Kim, P.M., additional, Laffon, B., additional, Lynn, J., additional, Martin, F., additional, Prorok, J.C., additional, Rockwood, K., additional, Rodrigues Mañas, L., additional, Rolfson, D., additional, Shaw, G., additional, Shea, B., additional, Sinha, S., additional, Theou, O., additional, Tugwell, P., additional, Valdiglesias, V., additional, Vellas, B., additional, Veronese, N., additional, Wallace, L.M.K., additional, and Williamson, P.R., additional
- Published
- 2019
- Full Text
- View/download PDF
7. Chapter 6 - The Application, Neurotoxicity, and Related Mechanism of Iron Oxide Nanoparticles
- Author
-
Kiliç, G., Fernández-Bertólez, N., Costa, C., Brandão, F., Teixeira, J.P., Pásaro, E., Laffon, B., and Valdiglesias, V.
- Published
- 2017
- Full Text
- View/download PDF
8. Life-course exposure and physical activity impact on genomic biomarkers of a group of older adults
- Author
-
Teixeira-Gomes, A., primary, Lage, B., additional, Silva, S., additional, Esteves, F., additional, Carvalho, J., additional, Valdiglesias, V., additional, Teixeira, J.P., additional, and Costa, S., additional
- Published
- 2018
- Full Text
- View/download PDF
9. Principales factores implicados en el empeoramiento del estado fenotípico de la fragilidad: seguimiento a un año
- Author
-
Lorenzo-López, L., primary, López-López, R., additional, Maseda, A., additional, Buján, A., additional, Valdiglesias, V., additional, and Millán-Calenti, J.C., additional
- Published
- 2018
- Full Text
- View/download PDF
10. Analysis of cellular damage induced by silica-coated iron oxide nanoparticles on neuronal cells
- Author
-
Laffon, Blanca, Kiliç, G., Fernandez Bertólez, N., Costa, C., Costa, S., Teixeira, J.P., Pásaro, E., and Valdiglesias, V.
- Subjects
Iron Oxide Nanoparticles ,Nanoparticles ,Genotoxicity ,Genotoxicidade Ambiental - Abstract
The objective of this work was to evaluate toxicity induced by silica-coated ION on a human neuronal cell line (SHSY5Y). This work was supported by Xunta de Galicia (EM 2012/079), the project NanoToxClass (ERA ERASIINN/ 001/2013), and by TD1204 MODENA COST Action. N/A
- Published
- 2016
11. REFERENCE RANGES OF LYMPHOCYTE SUBSETS IN NON-FRAIL OLDER ADULTS
- Author
-
Laffon, B., primary, Sánchez-Flores, M., additional, Marcos-Pérez, D., additional, Maseda, A., additional, Lorenzo-López, L., additional, Millán-Calenti, J., additional, Valdiglesias, V., additional, and Pásaro, E., additional
- Published
- 2017
- Full Text
- View/download PDF
12. SELECTIVE ATTENTION IN AGE-ASSOCIATED MEMORY IMPAIRMENT: AN ERP STUDY IN VISUAL SEARCH
- Author
-
Bujn, A., primary, Lorenzo-López, L., additional, Maseda, A., additional, López-López, R., additional, Diego-Diez, C., additional, Valdiglesias, V., additional, and Millán-Calenti, J., additional
- Published
- 2017
- Full Text
- View/download PDF
13. PRESCRIBED MEDICATION AND MALNOURISHMENT AT RISK OF MALNUTRITION
- Author
-
Maseda, A., primary, Bujn, A., additional, Lorenzo-López, L., additional, López-López, R., additional, Valdiglesias, V., additional, Laffon, B., additional, and Millán-Calenti, J., additional
- Published
- 2017
- Full Text
- View/download PDF
14. Effects of iron oxide nanoparticles: Cytotoxicity, genotoxicity, developmental toxicity, and neurotoxicity
- Author
-
Valdiglesias, V., Kiliç, G., Costa, C., Fernández-Bertólez, N, Pásaro, E., Teixeira, João Paulo, and Laffon, B.
- Subjects
Ar e Saúde Ocupacional ,Cytotoxicity ,Iron Oxide Nanoparticles ,Neurotoxicity ,Nanoparticles ,Toxicologia ,Genotoxicity ,Genotoxicidade Ambiental ,Developmental Toxicity - Abstract
Iron oxide nanoparticles (ION) with superparamagnetic properties hold great promise for use in various biomedical applications; specific examples include use as contrast agents for magnetic resonance imaging, in targeted drug delivery, and for induced hyperthermia cancer treatments. Increasing potential applications raise concerns over their potential effects on human health. Nevertheless, very little is currently known about the toxicity associated with exposure to these nanoparticles at different levels of biological organization. This article provides an overview of recent studies evaluating ION cytotoxicity, genotoxicity, developmental toxicity and neurotoxicity. Although the results of these studies are sometimes controversial, they generally indicate that surface coatings and particle size seem to be crucial for the observed ION-induced effects, as they are critical determinants of cellular responses and intensity of effects, and influence potential mechanisms of toxicity. The studies also suggest that some ION are safe for certain biomedical applications, while other uses need to be considered more carefully. Overall, the available studies provide insufficient evidence to fully assess the potential risks for human health related to ION exposure. Additional research in this area is required including studies on potential long-term effects.
- Published
- 2015
15. Micronucleus frequency in peripheral blood lymphocytes and frailty status in elderly. A lack of association with clinical features
- Author
-
Valdiglesias, V, Bonassi, S, Dell'Armi, V, Settanni, S, Celi, M, Mastropaolo, S, Antocicco, M, Fini, M, Onder, Graziano, Onder, Graziano (ORCID:0000-0003-3400-4491), Valdiglesias, V, Bonassi, S, Dell'Armi, V, Settanni, S, Celi, M, Mastropaolo, S, Antocicco, M, Fini, M, Onder, Graziano, and Onder, Graziano (ORCID:0000-0003-3400-4491)
- Abstract
Frailty is a condition of vulnerability that carries an increased risk of poor outcome in elder adults. Frail individuals show fatigue, weight loss, muscle weakness, and a reduced physical function, and are known to frequently experience disability, social isolation, and institutionalization. Identifying frail people is a critical step for geriatricians to provide timely geriatric care and, eventually, to improve the quality of life in elderly. The aim of the present study is to investigate the association between frailty status and micronucleus (MN) frequency, a known marker of genomic instability, in a sample of elder adults. Several clinical features were evaluated and their possible association with MN frequency was tested. Criteria proposed by Fried were used to identify frail subjects. Overall, 180 elder adults entered the study, 93 of them (51.7%) frail. No association between MN frequency and frailty status was found under the specific conditions tested in this study (mean ratio=1.06; 95% CI 0.96-1.18). The inclusion of MN frequency in the Fried's frailty scale minimally improved the classification of study subjects according to the multidimensional prognostic index (MPI). The presence of genomic instability in the ageing process and in most chronic diseases, demands further investigation on this issue.
- Published
- 2015
16. Silica-coated iron oxide nanoparticles do not induce DNA double strand breaks or aneugenicity in SHSY5Y neuronal cells
- Author
-
Sánchez-Flores, M., primary, Kiliç, G., additional, Costa, C., additional, Fernández-Bertólez, N., additional, Costa, S., additional, Teixeira, J.P., additional, Pásaro, E., additional, Valdiglesias, V., additional, and Laffon, B., additional
- Published
- 2015
- Full Text
- View/download PDF
17. In vitro toxicity screening of silica-coated superparamagnetic iron oxide nanoparticles in glial cells
- Author
-
Costa, C., primary, Brandão, F., additional, Bessa, M.J., additional, Costa, S., additional, Valdiglesias, V., additional, Kiliç, G., additional, Fernández-Bertólez, N., additional, Pásaro, E., additional, Laffon, B., additional, and Teixeira, J., additional
- Published
- 2015
- Full Text
- View/download PDF
18. Oxidative stress induced by silica-coated iron oxide nanoparticles in SHSY5Y neuronal cells
- Author
-
Kiliç, G., primary, Costa, C., additional, Fernández-Bertólez, N., additional, Costa, S., additional, Teixeira, Joao Paulo, additional, Pásaro, E., additional, Laffon, B., additional, Vdz Park, M., additional, and Valdiglesias, V., additional
- Published
- 2015
- Full Text
- View/download PDF
19. Shorter telomeres in peripheral blood mononuclear cells from older persons with sarcopenia: results from an exploratory study
- Author
-
Marzetti, Emanuele, Lorenzi, Maria, Antocicco, Manuela, Bonassi, S, Celi, Michela, Mastropaolo, Simona, Settanni, Silvana, Valdiglesias, V, Landi, Francesco, Bernabei, Roberto, Onder, Graziano, Marzetti, Emanuele (ORCID:0000-0001-9567-6983), Landi, Francesco (ORCID:0000-0002-3472-1389), Bernabei, Roberto (ORCID:0000-0002-9197-004X), Onder, Graziano (ORCID:0000-0003-3400-4491), Marzetti, Emanuele, Lorenzi, Maria, Antocicco, Manuela, Bonassi, S, Celi, Michela, Mastropaolo, Simona, Settanni, Silvana, Valdiglesias, V, Landi, Francesco, Bernabei, Roberto, Onder, Graziano, Marzetti, Emanuele (ORCID:0000-0001-9567-6983), Landi, Francesco (ORCID:0000-0002-3472-1389), Bernabei, Roberto (ORCID:0000-0002-9197-004X), and Onder, Graziano (ORCID:0000-0003-3400-4491)
- Abstract
Telomere shortening in peripheral blood mononuclear cells (PBMCs) has been associated with biological age and several chronic degenerative diseases. However, the relationship between telomere length and sarcopenia, a hallmark of the aging process, is unknown. The aim of the present study was therefore to determine whether PBMC telomeres obtained from sarcopenic older persons were shorter relative to non-sarcopenic peers. We further explored if PBMC telomere length was associated with frailty, a major clinical correlate of sarcopenia.
- Published
- 2014
20. Variation of DNA damage levels in peripheral blood mononuclear cells isolated in different laboratories
- Author
-
Godschalk, R. W. L., primary, Ersson, C., additional, St pnik, M., additional, Ferli ska, M., additional, Palus, J., additional, Teixeira, J. P., additional, Costa, S., additional, Jones, G. D. D., additional, Higgins, J. A., additional, Kain, J., additional, Moller, L., additional, Forchhammer, L., additional, Loft, S., additional, Lorenzo, Y., additional, Collins, A. R., additional, van Schooten, F.-J., additional, Laffon, B., additional, Valdiglesias, V., additional, Cooke, M., additional, Mistry, V., additional, Karbaschi, M., additional, Phillips, D. H., additional, Sozeri, O., additional, Routledge, M. N., additional, Nelson-Smith, K., additional, Riso, P., additional, Porrini, M., additional, Lopez de Cerain, A., additional, Azqueta, A., additional, Matullo, G., additional, Allione, A., additional, and Moller, P., additional
- Published
- 2014
- Full Text
- View/download PDF
21. An ECVAG inter-laboratory validation study of the comet assay: inter-laboratory and intra-laboratory variations of DNA strand breaks and FPG-sensitive sites in human mononuclear cells
- Author
-
Ersson, C., primary, Moller, P., additional, Forchhammer, L., additional, Loft, S., additional, Azqueta, A., additional, Godschalk, R. W. L., additional, van Schooten, F.-J., additional, Jones, G. D. D., additional, Higgins, J. A., additional, Cooke, M. S., additional, Mistry, V., additional, Karbaschi, M., additional, Phillips, D. H., additional, Sozeri, O., additional, Routledge, M. N., additional, Nelson-Smith, K., additional, Riso, P., additional, Porrini, M., additional, Matullo, G., additional, Allione, A., additional, Stepnik, M., additional, Ferlinska, M., additional, Teixeira, J. P., additional, Costa, S., additional, Corcuera, L.-A., additional, Lopez de Cerain, A., additional, Laffon, B., additional, Valdiglesias, V., additional, Collins, A. R., additional, and Moller, L., additional
- Published
- 2013
- Full Text
- View/download PDF
22. Cell cycle alterations and apoptosis assessment in SHSY5Y human neuroblastoma cells exposed to okadaic acid
- Author
-
Valdiglesias, V., primary, García-Lestón, J., additional, Pásaro, E., additional, Méndez, J., additional, and Laffon, B., additional
- Published
- 2010
- Full Text
- View/download PDF
23. List of Contributors
- Author
-
Abdolahi, A., Abdolghaffari, A.H., Abdollahi, M., Achanzar, W.E., Acquisto, N.M., Adatsi, F.K., Adekola, F.A., Agarwal, D., Aizawa, H., Akbar Malekirad, A., Allen, J.A., Allison, B., Alonso Blazquez, N., Altkorn, R., Amanlou, M., Amini, M., Anand, S.S., Andres, S.A., Angelini, D.J., Angelo, G., Api, A.M., Apte, U., Armendáriz, C.R., Asha, S., Atlason, P., Attene-Ramos, M.S., Austin, C.P., Babich, M.A., Badanthadka, M., Baeeri, M., Baer, K.N., Baghaei, A., Bahadar, H., Balali-Mood, B., Balali-Mood, M., Bale, A.S., Ballantyne, B., Banasik, M., Banks, C.N., Banton, M., Baran, K.P., Barata, C., Barefoot, A.C., Barlow, S.M., Barr, D.B., Barrueto, F., Barton, C., Barton, N., Battalora, M., Bayrami, Z., Bazl, R., Beckett, R.D., Bečková, V., Beedanagari, S., Behboudi, A.F., Beilke, L.D., Beltrán, E.M., Benson, A., Bergamo, L., Bergueiro, J., Berman, F.W., Betharia, S., Bhattacharya, S., Biglar, M., Biswas, S., Black, A.T., Bloomhuff, A.B., Bloomquist, J.R., Bolduc, D.L., Bolger, P.M., Bolt, H.M., Bonventre, J.A., Borek, H.A., Borghoff, S.J., Borzelleca, J.F., Botelho, M.C., Boxall, A.B.A., Bradford, H., Brady, P.M., Broderick, M., Brown, D.A., Brown, J., Bruce, R.D., Brugge, D., Brugger, K.E., Bryant, M.A., Bucklin, M.H., Burns-Naas, L.A., Burr, S.A., Caballero, J.M., Cai, Z., Calabrese, E.J., Calvo, M., Cammack, J., Campbell, A., Canedy, T., Cantrell, F.L., Caquet, T., Carbonell, G., Carlson-Lynch, H., Carmichael, N., Carmo, H., Carr, D., Carrington, C.D., Carvalho, F., Carvalho, M., Casa-Resino, I. de la, Cash, L.J., Castranova, V., Cesnaitis, R., Chadwick, K.D., Chakraborty, P., Chan, P.P.K., Chang, S., Chapin, R.E., Chateauvieux, S., Chattopadhyay, A., Chaumot, A., Chen, G., Chen, X., Chesser, R.K., Chilakapati, J., Chojnacka, K., Chou, K., Christoforidis, J., Clark, A.K., Clewell, H.J., Clough, S.R., Coelho, P.C.S., Coggins, C.R.E., Cohen, S.M., Cole, S.D., Corcoran, G.B., Cornu, C., Corsini, E., Cory-Slechta, D.A., Costa, C., Costa, L.G., Costa, S., Covaci, A., Cowden, J., Cumpston, K.L., Curfman, E., Czerczak, S., Daam, M.A., Dahlstrom, D.L., Darracq, M.A., Darwich, A.S., Das, S.R., Davis, J.A., de la Casa Resino, I., de la Torre, A.H., de Lourdes Bastos, M., del Río, E., de Marcellus, S., Demers, P.A., de Peyster, A., Derakhshani, M., Desai, S.N., de San Andrés Larrea, M.I., Descotes, J., Devi, S.S., Devlin, J.J., de Voogt, P., Devriese, L., DeWoskin, R.S., de Zwart, D., Diederich, M., Dieter, H.H., Di Guardo, A., Đikić, D., Dincer, I., Dissanayake, V., DiZio, S.M., Dodd-Butera, T., Doke, D., Dorsey, R.M., Dougherty, M.M., Dourson, M.L., Drake, V.J., Duffus, J.H., Dumancas, G.G., Dumbacher, J.P., DuTeaux, S.B., Dydek, S.T., Dykens, J.A., Eagle, S.R., Eastmond, D.A., Easton, J.D., Eidemiller, B.J., Eisen, E.A., Emami, A., Emami, S., Embry, M.R., Emswiler, M.P., Erraguntla, N.K., Escribano, M., Espín, S., Estevan, C., Estévez, J., Etemad, L., Everson, G.W., Ewers, L.M., Fain, J.H., Fan, A.M., Farris, F.F., Farshchi, A., Fatoki, O.S., Feakes, D., Feasel, M., Fedoruk, M.J., Feitshans, I.L., Fent, G.M., Fernández-Tajes, J., Fernández, Á.J.G., Fernández, C., Fernández Rodríguez, M.D., Ferrari, B., Fidalgo, J., Fields, A., Finch, G.L., Finizio, A., Finnveden, G., Fitzgerald, L., Foroumadi, A., Fuentes, D., Gad, K., Gad, S.C., Gad, S.E., Gadagbui, B., Gammon, D.W., García-Fernández, A.J., García Gómez, M.C., Gardner, D.E., Garrard, A., Garric, J., Gautam, G., Geffard, O., Genter, M.B., Gevaart-Durkin, A., Ghafouri, N., Ghazali, A.R., Ghoreishi, K., Ghosh, B., Gilbert, S.G., Giordano, G., Giouleme, O., Gironés, M.C.L.R., Gobba, F., Goel, S., Gohari, A.R., Gohlke, J.M., Golbabaei, S., Gold, S.C., Gómez-López, V.M., Gómez-Ramírez, P., González-Canga, A., González, G.L., Goodman, J.E., Gordon, E., Gordon, T., Gorodetsky, R., Gray, J.P., Green, M.D., Greim, H., Griffiths, J.C., Groth, C.M., Guedes de Pinho, P., Gupta, N., Gupta, R.C., Gutiérrez, A.J., Guy, R.C., Haber, L.T., Hacatoglu, K., Hahn, K., Haines, J.A., Hakkinen, P.J., Hall, E.J., Hall, G.J., Hall, V.R., Hambright, K.D., Handler, J.A., Hansen, D.K., Hanson, K.M., Hanson, M., Hardison, L.S., Hardisson, A., Harper, S.L., Hartmann, A.C., Hartung, T., Hartwig, A., Hassani, S., Hatlelid, K.M., Hayes, A.W., Hayes, A.N., Heidari, M.R., Henderson, J., Henriksen, B., Hernández-Moreno, D., Hertzberg, R.C., Hesterberg, T., Heyndrickx, M., Hicks, D., Hikkaduwa Koralege, R.S., Hilburn, M.E., Hinderliter, P., Hines, E.P., Hirakawa, B., Hirata, C.M., Ho, S., Hobson, D.W., Hoffmann, S., Holloway, A.C., Holstege, C.P., Holstege, E., Hon, S.L., Honeycutt, M., Hong, S., Hoover, M.D., Hopf, N.B., Hopp, A.G., Horiguchi, H., Hosseini-Tabatabaei, A., Hosseini, A., Hostetler, M.A., Hsu, C.H., Huang, F.X., Hulla, J.E., Hultén, P., Hultin, M.L., Hurst, H.E., Iannucci, A., Inayat-Hussain, S.H., Inselman, A.L., Iskander, J., Jabbour, R.E., Jaberidoost, M., Jacobs, M., Jamei, M., Jamison, K.P., Janes, M., Janz, D.M., Jazayeri, S.B., Jenkins, A., Jiang, M., Jin, N., John, K., Jones, L., Jones, P.D., Jordan, S.A., Jurado, A.S., Kalapos, M.P., Kamrin, M.A., Kapp, R.W., Karami-Mohajeri, S., Karanth, S., Karimi, G., Katz, S.A., Kem, W.R., Kempegowda, P., Kennedy, G.L., Kester, J.E., Khaksar, M.R., Kharabaf, S., Khoobi, M., Kiersma, M.E., Kilpinen, J.M., Kim, D.H., Kim, S.T., Kimbrough, R.D., Klein, S.J., Knechtges, P.L., Knuckles, T.L., Knudsen, T.B., Korrapati, M.C., Koshlukova, S.E., Kovacic, P., Kraft, A., Krafts, K., Krishnan, P., Kruger, C.L., Kubic, A., Kulkarni, S., Kwok, E.S.C., Laffon, B., Lagadic, L., Lambert, C.E., Landolph, J.R., Lange, R.W., Lank, P., Lari, P., Lasley, W., Lawana, V., Lazo, C.R., Ledrich, M.-L., Le Goff, F., Lein, P.J., Leung, H.-W., Leung, Y.L., Lewandowski, T.A., Li, X., Liesivuori, J., Lim, L., Limaye, P., Lin, H.H., Lin, S.C., Litovitz, T., Liu, F., Liu, J., Lloyd-Smith, M., Lo, J.C.Y., Loccisano, A.E., Logan, P., López, S., Lord-Garcia, J., Lotti, M., Luschützky, E., Mahdaviani, P., Maier, A., Makhaeva, G.F., Malátová, I., Malekirad, A.A., Manayi, A., Mangas, I., Mangino, M., Mangipudy, R.S., Maples, R.D., Marcel, B.J., Marigómez, I., Marraffa, J.M., Martínez-López, E., Mathews, S.M., Maxim, L.D., Maxwell-Stuart, P.G., Mayor, A., McClane, B.A., McCoole, M.D., McCormick, D.B., McGregor, D., McKee, J.M., McMartin, K., Meek, B., Megharaj, M., Mehendale, H.M., Mehrpour, O., Mendes, A., Méndez, J., Menn, F.-M., Meyer, S.A., Michalak, I., Míguez-Santiyán, M.P., Mikulewicz, M., Milanez, S., Mileson, B.E., Miller, G.W., Miller, S.J., Miller, S.M., Millner, G.C., Minarchick, V.C., Miracle, A.L., Mirajkar, N.S., Mirkes, P.E., Mitra, M.S., Mody, V., Mogl, S., Mohammadirad, A., Mojica, E.-R.E., Molander, L., Molina López, A.M., Momen-Heravi, F., Montague, P., Monteiro, J.P., Monticelli, F., Morceau, F., Moreno, M., Morgan, B.W., Mortensen, S.R., Moser, V.C., Moshiri, M., Mostafalou, S., Moyer, R.A., Mumy, K.L., Munday, R., Murdianti, B.S., Murray, A., Murray, T.M., Murta, T.L., Nadri, H., Naidu, R., Naile, J.E., Naistat, D.M., Nakajima, T., Nalliah, R.E., Nance, P., Nathan, S., Navarro, L., Navas, I.M., Nelson, L.S., Nerin, C., Newsted, J., Nikfar, S., Nili-Ahmadabadi, A., Nobay, F., Nony, P., Nurkiewicz, T.R., Oi, M., Okoro, H.K., Oliveira, P.A., Olsen, L.R., Oropesa Jiménez, A.L., Othumpangat, S., Pablos, M.V., Pakulska, D., Pakzad, M., Pallasch, E.M., Pamies, D., Parihar, H.S., Parmar, M.S., Parod, R.J., Paschos, P., Patterson, J., Patterson, T.J., Patterson, T.A., Paulo Teixeira, J., Pawlaczyk, A., Pearson, M.A., Pellerano, M.B., Pellizzato, F., Perales, C.M., Peredy, T., Pereira, J., Pérez-López, M., Peri, R., Persad, A.S., Persson, H., Perwaiz, S., Peterson, M.K., Pham, P.J., Pham, T., Philip, B.K., Pichery, C., Pickett, A.J., Piña, B., Pinkerton, K.E., Pleus, R.C., Podder, S., Poirier, M.C., Pomerleau, A.C., Pope, C., Posthuma, L., Potting, J., Pournourmohammadi, S., Pravasi, S.D., Preston, R.J., Prusakov, P.A., Punja, M., Puran, A.C., Purcell, M.M., Qian, L., Qozi, M., Quintana, P.J.E., Rabiei, M., Radulovic, L.L., Rahmani, N., Rajabi, M., Raman, P., Ramasahayam, S., Ramos-Peralonso, M.J., Rankin, G.O., Rao, C.V., Rao, P.S., Rashedinia, M., Rath, A.D., Ray, D.E., Ray, S.D., Reed, N.R., Remião, F., Rezaee, R., Rezvanfar, M.A., Rezvani, N., Rhomberg, L.R., Riar, N.K., Rice, G., Richardson, J.R., Richardson, R.J., Richter, P., Rider, G., Rivera, H.L., Robbens, J., Roberts, D.J., Roberts, L.G., Robinson, P.J., Robles, H., Rodgers, B.E., Rodgers, K., Rodriguez, Y.R., Rodriguez Fernández, C., Roede, J.R., Rogawski, M.A., Rojo, L., Romano, J.A., Rose, S.R., Rosen, M.A., Rossol, M., Rostami–Hodjegan, A., Rourke, J.L., Roy, R., Roy, S.S., Rozman, K.K., Rubin, A.L., Rubio, C., Ruch, R.J., Rumbeiha, W.K., Rushton, W., Sabzevari, O., Saeedi, M., Saeid, A., Saeidnia, S., Saghir, S.A., Saili, K.S., Salem, H., Salvago, M.R. Moyano, Salvatore, J.R., San Andrés Larrea, M.D., San Andrés Larrea, M.I., Sarazan, R.D., Sardari, S., Sasaki, T., Sawant, S.P., Schaeffer, V., Schep, L.J., Schlesinger, R.B., Schneider, S.M., Schreffler, S.M., Schultz, M.M., Schwartz, M., Schwela, D., Scott, A.L., Scott, B.R., Scribner, K., Seabury, R.W., Seco, B., Seeley, M., Seifert, J., Sellamuthu, R., Serex, T.L., Sexton, K., Shadnia, S., Shafiee, A., Shah, I., Shankar, K., Sheets, L.P., Sheppard, L., Shiotsuka, R.N., Shirley, S., Shojaei Saadi, H.A., Sibbald, K.N., Sidell, F.R., Siegrist, M., Simmons, J.E., Sinal, C.J., Singh, P., Skoglund, R., Skonberg, C., Slaughter, R.J., Sledge, C.L., Slothower, J.D., Smith, M., Smith, M.T., Snider, D.B., Snyman, R.G., Sobanska, M., Sogorb, M.Á., Soler-Rodríguez, F., Solgi, R., Solomon, K.R., Somanathan, R., Sonawane, B.R., Song, X., Soni, M.G., Sorensen, J., Soucy, N.V., Southard, R.J., Spainhour, C.B., Spencer, P.S., Spiller, H.A., Spoelhof, B., Stanard, B., Stanek, L.W., Stapleton, P.A., Stedeford, T., Steidl-Nichols, J., Stephens, M., Steyn, N.P., Stickney, J., Stohs, S.J., Stone, D., Stool, D., Stork, C.M., Strohm, B., Stromberg, P.E., Sullivan, D.W., Sullivan, M.R., Sultatos, L.G., Suryanarayanan, A., Syed, I., Szabo, D.T., Szynkowska, M.I., Takacs, Z., Talaska, G., Talbot, P., Tanguay, R.L., Tarazona, J.V., Teixeira, J.P., Temple, N.J., Temple, W.A., Tena, A., Teuschler, L.K., Thackaberry, E.A., Thakore, K.N., Theodorakis, C., Thompson, R.E., Thornton, S.L., Ting, D., Tirmenstein, M.A., Touwaide, A., Towne, T.G., Traven, S.A., Tritscher, A., Troendle, M., Trosko, J.E., Tsai, W.-T., Tsai-Turton, M., Tsatsakis, A., Tsitsimpikou, C., Tsubura, A., Tsuda, T., Tyl, R.W., Udarbe Zamora, E.M., Utell, M.J., Vahabzadeh, M., Vaidya, V.S., Valdiglesias, V., Valentovic, M.A., Valerio, L.G., Vales, T., Vandenberg, L.N., van den Brink, P.J., van der Kolk, J., Van Vleet, T.R., van Vliet, E., Varga, J., Venkateswarlu, K., Verslycke, T., Versonnen, B., Verstraete, K., Vighi, M., Vilanova, E., Vincent, L., Vincent, M., Visser, R., Volger, B., von Stackelberg, K., Vulimiri, S.V., Wahl, M., Walker, N.J., Walker, T.D., Wallace, D.R., Wang, C., Wang, G.S., Wanna-Nakamura, S.C., Watson, R.E., Wattenberg, E.V., Wax, P.M., Weaver, J.A., Webber, N.R., Weber, J.A., Weber, L.P., Weinrich, A.J., Weiss, B., Wennberg, A., Wernke, M.J., Weston, A., Wexler, P., White, L.D., Whittaker, M.H., Wiedenfeld, H., Wiegand, T.J., Wikoff, D.S., Wild, C.P., Will, Y., Willett, C., Willhite, C.C., Willis, A., Willis, K., Wills, B.K., Wilson, B.W., Wittliff, J.L., Wojcinski, Z.W., Wolfe, M.S., Wood, C.S., Woodall, G.M., Woolley, A., Xia, M., Ximba, B.J., Yan, B., Yanagiba, Y., Yang, D., Yang, N., Yoon, M., Yorifuji, T., Yoshizawa, K., Young, R.A., Zamor, R.M., and Zhao, Q.J.
- Published
- 2014
- Full Text
- View/download PDF
24. An overview on micronucleus assay evaluation by flow cytometry
- Author
-
Sánchez-Flores, M., Pásaro, E., Blanca Laffon, and Valdiglesias, V.
25. DNA damage related to exposure to oil spills: The Prestige experience
- Author
-
Pérez-Cadahía, B., Méndez, J., Pásaro, E., Valdiglesias, V., and Blanca Laffon
26. The importance of the in vitro genotoxicity evaluation of food components: The selenium
- Author
-
Valdiglesias, V., Méndez, J., Pásaro, E., and Blanca Laffon
27. Moving Towards Common Data Elements and Core Outcome Measures in Frailty Research
- Author
-
Olga Theou, Paula R Williamson, Matteo Cesari, Darryl B. Rolfson, H. E. Eriksen, I. Araujo de Carvalho, Beverley Shea, Jeanette Prorok, George A. Heckman, Samir K. Sinha, G. Shaw, Lindsay M. K. Wallace, Bruno Vellas, Andrew Clegg, V. Valdiglesias, Nicola Veronese, K. R. Evans, John Muscedere, B. Laffon, J. Lynn, John P. Hirdes, Kenneth Rockwood, P. Tugwell, L. Rodrigues Mañas, Finbarr C. Martin, Jonathan Afilalo, Perry Kim, Muscedere, J., Afilalo, J., Araujo de Carvalho, I., Cesari, M., Clegg, A., Eriksen, H.E., Evans, K.R., Heckman, G., Hirdes, J.P., Kim, P.M., Laffon, B., Lynn, J., Martin, F., Prorok, J.C., Rockwood, K., Rodrigues Mañas, L., Rolfson, D., Shaw, G., Shea, B., Sinha, S., Theou, O., Tugwell, P., Valdiglesias, V., Vellas, B., Veronese, N., Wallace, L.M.K., and Williamson, P.R.
- Subjects
Gerontology ,Canada ,Biomedical Research ,Common Data Elements ,Consensus ,Conceptualization ,Frailty ,business.industry ,Frailty, common data elements, core outcome measures ,Outcome measures ,General Medicine ,Evidence-based medicine ,030204 cardiovascular system & hematology ,Frailty assessment ,Clinical trial ,03 medical and health sciences ,Identification (information) ,Core (game theory) ,0302 clinical medicine ,Social system ,Outcome Assessment, Health Care ,Medicine ,Humans ,030212 general & internal medicine ,business - Abstract
With aging populations around the world, frailty is becoming more prevalent increasing the need for health systems and social systems to deliver optimal evidence based care. However, in spite of the growing number of frailty publications, high-quality evidence for decision making is often lacking. Inadequate descriptions of the populations enrolled including frailty severity and frailty conceptualization, lack of use of validated frailty assessment tools, utilization of different frailty instruments between studies, and variation in reported outcomes impairs the ability to interpret, generalize and implement the research findings. The utilization of common data elements (CDEs) and core outcome measures (COMs) in clinical trials is increasingly being adopted to address such concerns. To catalyze the development and use of CDEs and COMs for future frailty studies, the Canadian Frailty Network (www.cfn-nce.ca; CFN), a not-for-profit pan-Canadian nationally-funded research network, convened an international group of experts to examine the issue and plan the path forward. The meeting was structured to allow for an examination of current frailty evidence, ability to learn from other COMs and CDEs initiatives, discussions about specific considerations for frailty COMs and CDEs and finally the identification of the necessary steps for a COMs and CDEs consensus initiative going forward. It was agreed at the onset of the meeting that a statement based on the meeting would be published and herein we report the statement.
- Published
- 2020
28. Association between cognitive reserve proxies and frailty phenotype: data from UK Biobank.
- Author
-
Lorenzo-López L, Cibeira N, Hemadeh A, López-López R, Lema-Arranz C, Maseda A, Fernández-Bertólez N, Costa S, Pásaro E, Valdiglesias V, Millán-Calenti JC, and Laffon B
- Abstract
A potential protective role of cognitive reserve proxies against frailty has been suggested in older adults. We explored the cross-sectional association between cognitive reserve indicators and frailty phenotype. Data were obtained from the UK Biobank. We included 31,975 dementia-free participants aged ≥ 60 years (50.7% females, 2.2% frail) who completed a web-based cognitive assessment (fluid intelligence, working memory, visuospatial attention and processing speed, and executive functioning). Frailty was defined according to the Fried's phenotype (unintentional weight loss, exhaustion, low physical activity, slowness, and weakness). Participants meeting three or more criteria were classified as frail. Cognitive performance was compared between nonfrail and frail groups, and regression models were employed to analyze the associations between cognitive reserve proxies (education, skill level of occupation, social support, and multiple deprivation index (MDI)) and the likelihood of frailty. Frail and nonfrail groups significantly differed on cognitive function, with frail individuals demonstrating poorer performance on all cognitive functions (all p < .05) except fluid intelligence. Regression analysis showed that, after adjusting for age and sex, a lower educational level (odds ratio (OR) .797, 95% confidence interval (CI) .673-.944, p = .009), having maintained occupations with low cognitive requirements (OR .790, 95% CI .668-.936, p = .006), having less social support (OR .755, 95% CI .631-.903, p = .002), and living in a region with a high rate of multiple deprivation (OR 1.025, 95% CI 1.019-1.031, p < .001), significantly increased the probability of experiencing frailty. Our findings support the relationship between declined cognitive functions and frailty emphasizing the importance of implementing public health measures to enhance cognitive reserve., (© 2024. The Author(s), under exclusive licence to American Aging Association.)
- Published
- 2024
- Full Text
- View/download PDF
29. Toxicity of zinc oxide nanoparticles: Cellular and behavioural effects.
- Author
-
Fernández-Bertólez N, Alba-González A, Touzani A, Ramos-Pan L, Méndez J, Reis AT, Quelle-Regaldie A, Sánchez L, Folgueira M, Laffon B, and Valdiglesias V
- Subjects
- Animals, Humans, Metal Nanoparticles toxicity, DNA Damage, Cell Survival drug effects, Behavior, Animal drug effects, Comet Assay, Neuroglia drug effects, Nanoparticles toxicity, Zinc Oxide toxicity, Zebrafish
- Abstract
Due to their extensive use, the release of zinc oxide nanoparticles (ZnO NP) into the environment is increasing and may lead to unintended risk to both human health and ecosystems. Access of ZnO NP to the brain has been demonstrated, so their potential toxicity on the nervous system is a matter of particular concern. Although evaluation of ZnO NP toxicity has been reported in several previous studies, the specific effects on the nervous system are not completely understood and, particularly, effects on genetic material and on organism behaviour are poorly addressed. We evaluated the potential toxic effects of ZnO NP in vitro and in vivo, and the role of zinc ions (Zn
2+ ) in these effects. In vitro, the ability of ZnO NP to be internalized by A172 glial cells was verified, and the cytotoxic and genotoxic effects of ZnO NP or the released Zn2+ ions were addressed by means of vital dye exclusion and comet assay, respectively. In vivo, behavioural alterations were evaluated in zebrafish embryos using a total locomotion assay. ZnO NP induced decreases in viability of A172 cells after 24 h of exposure and genetic damage after 3 and 24 h. The involvement of the Zn2+ ions released from the NP in genotoxicity was confirmed. ZnO NP exposure also resulted in decreased locomotor activity of zebrafish embryos, with a clear role of released Zn2+ ions in this effect. These findings support the toxic potential of ZnO NP showing, for the first time, genetic effects on glial cells and proving the intervention of Zn2+ ions., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF
30. Toxoplasma gondii IgG Serointensity Is Positively Associated With Frailty.
- Author
-
Mohyuddin H, Laffon B, Teixeira JP, Costa S, Teixeira-Gomes A, Pásaro E, Constantine N, Dagdag A, Ortmeyer HK, Tizenberg B, Afram L, Yen P, Marano C, Lowry CA, Hoisington AJ, RachBeisel JA, Valdiglesias V, Lema-Arranz C, Fernández-Bertólez N, Maseda A, Millán-Calenti JC, Kovacs EJ, Gostner JM, Fuchs D, Brenner LA, Lorenzo-López L, and Postolache TT
- Subjects
- Humans, Female, Aged, Male, Cross-Sectional Studies, Immunoglobulin G, Antibodies, Protozoan, Biomarkers, Immunoglobulin M, Risk Factors, Toxoplasma, Toxoplasmosis, Frailty
- Abstract
Background: Persistent inflammation related to aging ("inflammaging") is exacerbated by chronic infections and contributes to frailty in older adults. We hypothesized associations between Toxoplasma gondii (T. gondii), a common parasite causing an oligosymptomatic unremitting infection, and frailty, and secondarily between T. gondii and previously reported markers of immune activation in frailty., Methods: We analyzed available demographic, social, and clinical data in Spanish and Portuguese older adults [N = 601; age: mean (SD) 77.3 (8.0); 61% women]. Plasma T. gondii immunoglobulin G (IgG) serointensity was measured with an enzyme-linked immunosorbent assay. The Fried criteria were used to define frailty status. Validated translations of Mini-Mental State Examination, Geriatric Depression Scale, and the Charlson Comorbidity Index were used to evaluate confounders. Previously analyzed biomarkers that were significantly associated with frailty in both prior reports and the current study, and also related to T. gondii serointensity, were further accounted for in multivariable logistic models with frailty as outcome., Results: In T. gondii-seropositives, there was a significant positive association between T. gondii IgG serointensity and frailty, accounting for age (p = .0002), and resisting adjustment for multiple successive confounders. Among biomarkers linked with frailty, kynurenine/tryptophan and soluble tumor necrosis factor receptor II were positively associated with T. gondii serointensity in seropositives (p < .05). Associations with other biomarkers were not significant., Conclusions: This first reported association between T. gondii and frailty is limited by a cross-sectional design and warrants replication. While certain biomarkers of inflammaging were associated with both T. gondii IgG serointensity and frailty, they did not fully mediate the T. gondii-frailty association., (© The Author(s) 2023. Published by Oxford University Press on behalf of The Gerontological Society of America.)
- Published
- 2024
- Full Text
- View/download PDF
31. Long-term cryopreservation of potassium bromate positive assay controls for measurement of oxidatively damaged DNA by the Fpg-modified comet assay: results from the hCOMET ring trial.
- Author
-
Møller P, Azqueta A, Rodriguez-Garraus A, Bakuradze T, Richling E, Bankoglu EE, Stopper H, Claudino Bastos V, Langie SAS, Jensen A, Ristori S, Scavone F, Giovannelli L, Wojewódzka M, Kruszewski M, Valdiglesias V, Laffon B, Costa C, Costa S, Paulo Teixeira J, Marino M, Del Bo' C, Riso P, Zheng C, Shaposhnikov S, and Collins A
- Abstract
The formamidopyrimidine DNA glycosylase (Fpg)-modified comet assay is widely used for the measurement of oxidatively generated damage to DNA. However, there has not been a recommended long-term positive control for this version of the comet assay. We have investigated potassium bromate as a positive control for the Fpg-modified comet assay because it generates many Fpg-sensitive sites with a little concurrent generation of DNA strand breaks. Eight laboratories used the same procedure for the treatment of monocytic THP-1 cells with potassium bromate (0, 0.5, 1.5, and 4.5 mM) and subsequent cryopreservation in a freezing medium consisting of 50% foetal bovine serum, 40% RPMI-1640 medium, and 10% dimethyl sulphoxide. The samples were analysed by the Fpg-modified comet assay three times over a 3-year period. All laboratories obtained a positive concentration-response relationship in cryopreserved samples (linear regression coefficients ranging from 0.79 to 0.99). However, there was a wide difference in the levels of Fpg-sensitive sites between the laboratory with the lowest (4.2% Tail DNA) and highest (74% Tail DNA) values in THP-1 cells after exposure to 4.5 mM KBrO3. In an attempt to assess sources of inter-laboratory variation in Fpg-sensitive sites, comet images from one experiment in each laboratory were forwarded to a central laboratory for visual scoring. There was high consistency between measurements of %Tail DNA values in each laboratory and the visual score of the same comets done in the central laboratory (r = 0.98, P < 0.001, linear regression). In conclusion, the results show that potassium bromate is a suitable positive comet assay control., (© The Author(s) 2023. Published by Oxford University Press on behalf of the UK Environmental Mutagen Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2023
- Full Text
- View/download PDF
32. Inter-laboratory variation in measurement of DNA damage by the alkaline comet assay in the hCOMET ring trial.
- Author
-
Møller P, Azqueta A, Collia M, Bakuradze T, Richling E, Bankoglu EE, Stopper H, Bastos VC, Langie SAS, Jensen A, Ristori S, Scavone F, Giovannelli L, Wojewódzka M, Kruszewski M, Valdiglesias V, Laffon B, Costa C, Costa S, Teixeira JP, Marino M, Del Bo C, Riso P, Zheng C, Shaposhnikov S, and Collins A
- Abstract
The comet assay is a simple and versatile method for measurement of DNA damage in eukaryotic cells. More specifically, the assay detects DNA migration from agarose gel-embedded nucleoids, which depends on assay conditions and the level of DNA damage. Certain steps in the comet assay procedure have substantial impact on the magnitude of DNA migration (e.g. electric potential and time of electrophoresis). Inter-laboratory variation in DNA migration levels occurs because there is no agreement on optimal assay conditions or suitable assay controls. The purpose of the hCOMET ring trial was to test potassium bromate (KBrO3) as a positive control for the formamidopyrimidine DNA glycosylase (Fpg)-modified comet assay. To this end, participating laboratories used semi-standardized protocols for cell culture (i.e. cell culture, KBrO3 exposure, and cryopreservation of cells) and comet assay procedures, whereas the data acquisition was not standardized (i.e. staining of comets and image analysis). Segregation of the total variation into partial standard deviation (SD) in % Tail DNA units indicates the importance of cell culture procedures (SD = 10.9), comet assay procedures (SD = 12.3), staining (SD = 7.9) and image analysis (SD = 0.5) on the overall inter-laboratory variation of DNA migration (SD = 18.2). Future studies should assess sources of variation in each of these steps. On the positive side, the hCOMET ring trial demonstrates that KBrO3 is a robust positive control for the Fpg-modified comet assay. In conclusion, the hCOMET ring trial has demonstrated a high reproducibility of detecting genotoxic effects by the comet assay, but inter-laboratory variation of DNA migration levels is a concern., (© The Author(s) 2023. Published by Oxford University Press on behalf of the UK Environmental Mutagen Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2023
- Full Text
- View/download PDF
33. DNA strand break levels in cryopreserved mononuclear blood cell lines measured by the alkaline comet assay: results from the hCOMET ring trial.
- Author
-
Møller P, Azqueta A, Rodriguez-Garraus A, Bakuradze T, Richling E, Bankoglu EE, Stopper H, Claudino Bastos V, Langie SAS, Jensen A, Ristori S, Scavone F, Giovannelli L, Wojewódzka M, Kruszewski M, Valdiglesias V, Laffon B, Costa C, Costa S, Paulo Teixeira J, Marino M, Del Bo C, Riso P, Zheng C, Shaposhnikov S, and Collins A
- Subjects
- Comet Assay methods, Cryopreservation methods, DNA metabolism, Leukocytes, Mononuclear metabolism, DNA Damage
- Abstract
The comet assay is widely used in biomonitoring studies for the analysis of DNA damage in leukocytes and peripheral blood mononuclear cells. Rather than processing blood samples directly, it can be desirable to cryopreserve whole blood or isolated cells for later analysis by the comet assay. However, this creates concern about artificial accumulation of DNA damage during cryopreservation. In this study, 10 laboratories used standardized cryopreservation and thawing procedures of monocytic (THP-1) or lymphocytic (TK6) cells. Samples were cryopreserved in small aliquots in 50% foetal bovine serum, 40% cell culture medium, and 10% dimethyl sulphoxide. Subsequently, cryopreserved samples were analysed by the standard comet assay on three occasions over a 3-year period. Levels of DNA strand breaks in THP-1 cells were increased (four laboratories), unaltered (four laboratories), or decreased (two laboratories) by long-term storage. Pooled analysis indicates only a modest positive association between storage time and levels of DNA strand breaks in THP-1 cells (0.37% Tail DNA per year, 95% confidence interval: -0.05, 0.78). In contrast, DNA strand break levels were not increased by cryopreservation in TK6 cells. There was inter-laboratory variation in levels of DNA strand breaks in THP-1 cells (SD = 3.7% Tail DNA) and TK6 reference sample cells (SD = 9.4% Tail DNA), whereas the intra-laboratory residual variation was substantially smaller (i.e. SD = 0.4%-2.2% Tail DNA in laboratories with the smallest and largest variation). In conclusion, the study shows that accumulation of DNA strand breaks in cryopreserved mononuclear blood cell lines is not a matter of concern., (© The Author(s) 2023. Published by Oxford University Press on behalf of the UK Environmental Mutagen Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2023
- Full Text
- View/download PDF
34. Visual comet scoring revisited: a guide to scoring comet assay slides and obtaining reliable results.
- Author
-
Møller P, Azqueta A, Sanz-Serrano J, Bakuradze T, Richling E, Eyluel Bankoglu E, Stopper H, Claudino Bastos V, Langie SAS, Jensen A, Scavone F, Giovannelli L, Wojewódzka M, Kruszewski M, Valdiglesias V, Laffon B, Costa C, Costa S, Teixeira JP, Marino M, Del Bo C, Riso P, Zheng C, Shaposhnikov S, and Collins A
- Abstract
Measurement of DNA migration in the comet assay can be done by image analysis or visual scoring. The latter accounts for 20%-25% of the published comet assay results. Here we assess the intra- and inter-investigator variability in visual scoring of comets. We include three training sets of comet images, which can be used as reference for researchers who wish to use visual scoring of comets. Investigators in 11 different laboratories scored the comet images using a five-class scoring system. There is inter-investigator variation in the three training sets of comets (i.e. coefficient of variation (CV) = 9.7%, 19.8%, and 15.2% in training sets I-III, respectively). However, there is also a positive correlation of inter-investigator scoring in the three training sets (r = 0.60). Overall, 36% of the variation is attributed to inter-investigator variation and 64% stems from intra-investigator variation in scoring between comets (i.e. the comets in training sets I-III look slightly different and this gives rise to heterogeneity in scoring). Intra-investigator variation in scoring was also assessed by repeated analysis of the training sets by the same investigator. There was larger variation when the training sets were scored over a period of six months (CV = 5.9%-9.6%) as compared to 1 week (CV = 1.3%-6.1%). A subsequent study revealed a high inter-investigator variation when premade slides, prepared in a central laboratory, were stained and scored by investigators in different laboratories (CV = 105% and 18%-20% in premade slides with comets from unexposed and hydrogen peroxide-exposed cells, respectively). The results indicate that further standardization of visual scoring is desirable. Nevertheless, the analysis demonstrates that visual scoring is a reliable way of analysing DNA migration in comets., (© The Author(s) 2023. Published by Oxford University Press on behalf of the UK Environmental Mutagen Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2023
- Full Text
- View/download PDF
35. Effects of Zinc Oxide Nanoparticle Exposure on Human Glial Cells and Zebrafish Embryos.
- Author
-
Valdiglesias V, Alba-González A, Fernández-Bertólez N, Touzani A, Ramos-Pan L, Reis AT, Moreda-Piñeiro J, Yáñez J, Laffon B, and Folgueira M
- Subjects
- Animals, Humans, Zebrafish, Neuroglia, Ions, Zinc Oxide toxicity, Zinc Oxide chemistry, Nanoparticles toxicity, Metal Nanoparticles toxicity
- Abstract
Zinc oxide nanoparticles (ZnO NPs) are among the most widely used nanomaterials. They have multiple applications in cosmetics, textiles, paints, electronics and, recently, also in biomedicine. This extensive use of ZnO NPs notably increases the probability that both humans and wildlife are subjected to undesirable effects. Despite being among the most studied NPs from a toxicological point of view, much remains unknown about their ecotoxicological effects or how they may affect specific cell types, such as cells of the central nervous system. The main objective of this work was to investigate the effects of ZnO NPs on human glial cells and zebrafish embryo development and to explore the role of the released Zn
2+ ions in these effects. The effects on cell viability on human A172 glial cells were assessed with an MTT assay and morphological analysis. The potential acute and developmental toxicity was assessed employing zebrafish ( Danio rerio ) embryos. To determine the role of Zn2+ ions in the in vitro and in vivo observed effects, we measured their release from ZnO NPs with flame atomic absorption spectrometry. Then, cells and zebrafish embryos were treated with a water-soluble salt (zinc sulfate) at concentrations that equal the number of Zn2+ ions released by the tested concentrations of ZnO NPs. Exposure to ZnO NPs induced morphological alterations and a significant decrease in cell viability depending on the concentration and duration of treatment, even after removing the overestimation due to NP interference. Although there were no signs of acute toxicity in zebrafish embryos, a decrease in hatching was detected after exposure to the highest ZnO NP concentrations tested. The ability of ZnO NPs to release Zn2+ ions into the medium in a concentration-dependent manner was confirmed. Zn2+ ions did not seem entirely responsible for the effects observed in the glial cells, but they were likely responsible for the decrease in zebrafish hatching rate. The results obtained in this work contribute to the knowledge of the toxicological potential of ZnO NPs.- Published
- 2023
- Full Text
- View/download PDF
36. Multiparametric in vitro genotoxicity assessment of different variants of amorphous silica nanomaterials in rat alveolar epithelial cells.
- Author
-
Brandão F, Costa C, Bessa MJ, Valdiglesias V, Hellack B, Haase A, Fraga S, and Teixeira JP
- Subjects
- Rats, Humans, Animals, Silicon Dioxide toxicity, DNA Damage, Comet Assay, Alveolar Epithelial Cells, Nanostructures toxicity
- Abstract
The hazard posed to human health by inhaled amorphous silica nanomaterials (aSiO
2 NM) remains uncertain. Herein, we assessed the cyto- and genotoxicity of aSiO2 NM variants covering different sizes (7, 15, and 40 nm) and surface modifications (unmodified, phosphonate-, amino- and trimethylsilyl-modified) on rat alveolar epithelial (RLE-6TN) cells. Cytotoxicity was evaluated at 24 h after exposure to the aSiO2 NM variants by the lactate dehydrogenase (LDH) release and WST-1 reduction assays, while genotoxicity was assessed using different endpoints: DNA damage (single- and double-strand breaks [SSB and DSB]) by the comet assay for all aSiO2 NM variants; cell cycle progression and γ-H2AX levels (DSB) by flow cytometry for those variants that presented higher cytotoxic and DNA damaging potential. The variants with higher surface area demonstrated a higher cytotoxic potential (SiO2 _7, SiO2 _15_Unmod, SiO2 _15_Amino, and SiO2 _15_Phospho). SiO2 _40 was the only variant that induced significant DNA damage on RLE-6TN cells. On the other hand, all tested variants (SiO2 _7, SiO2 _15_Unmod, SiO2 _15_Amino, and SiO2 _40) significantly increased total γ-H2AX levels. At high concentrations (28 µg/cm2 ), a decrease in G0 /G1 subpopulation was accompanied by a significant increase in S and G2 /M sub-populations after exposure to all tested materials except for SiO2 _40 which did not affect cell cycle progression. Based on the obtained data, the tested variants can be ranked for its genotoxic DNA damage potential as follows: SiO2 _7 = SiO2 _40 = SiO2 _15_Unmod > SiO2 _15_Amino. Our study supports the usefulness of multiparametric approaches to improve the understanding on NM mechanisms of action and hazard prediction.- Published
- 2023
- Full Text
- View/download PDF
37. Measuring DNA modifications with the comet assay: a compendium of protocols.
- Author
-
Collins A, Møller P, Gajski G, Vodenková S, Abdulwahed A, Anderson D, Bankoglu EE, Bonassi S, Boutet-Robinet E, Brunborg G, Chao C, Cooke MS, Costa C, Costa S, Dhawan A, de Lapuente J, Bo' CD, Dubus J, Dusinska M, Duthie SJ, Yamani NE, Engelward B, Gaivão I, Giovannelli L, Godschalk R, Guilherme S, Gutzkow KB, Habas K, Hernández A, Herrero O, Isidori M, Jha AN, Knasmüller S, Kooter IM, Koppen G, Kruszewski M, Ladeira C, Laffon B, Larramendy M, Hégarat LL, Lewies A, Lewinska A, Liwszyc GE, de Cerain AL, Manjanatha M, Marcos R, Milić M, de Andrade VM, Moretti M, Muruzabal D, Novak M, Oliveira R, Olsen AK, Owiti N, Pacheco M, Pandey AK, Pfuhler S, Pourrut B, Reisinger K, Rojas E, Rundén-Pran E, Sanz-Serrano J, Shaposhnikov S, Sipinen V, Smeets K, Stopper H, Teixeira JP, Valdiglesias V, Valverde M, van Acker F, van Schooten FJ, Vasquez M, Wentzel JF, Wnuk M, Wouters A, Žegura B, Zikmund T, Langie SAS, and Azqueta A
- Subjects
- Animals, Humans, Comet Assay methods, Eukaryotic Cells, DNA genetics, DNA Damage, Pyrimidine Dimers
- Abstract
The comet assay is a versatile method to detect nuclear DNA damage in individual eukaryotic cells, from yeast to human. The types of damage detected encompass DNA strand breaks and alkali-labile sites (e.g., apurinic/apyrimidinic sites), alkylated and oxidized nucleobases, DNA-DNA crosslinks, UV-induced cyclobutane pyrimidine dimers and some chemically induced DNA adducts. Depending on the specimen type, there are important modifications to the comet assay protocol to avoid the formation of additional DNA damage during the processing of samples and to ensure sufficient sensitivity to detect differences in damage levels between sample groups. Various applications of the comet assay have been validated by research groups in academia, industry and regulatory agencies, and its strengths are highlighted by the adoption of the comet assay as an in vivo test for genotoxicity in animal organs by the Organisation for Economic Co-operation and Development. The present document includes a series of consensus protocols that describe the application of the comet assay to a wide variety of cell types, species and types of DNA damage, thereby demonstrating its versatility., (© 2023. Springer Nature Limited.)
- Published
- 2023
- Full Text
- View/download PDF
38. Assessing the in vitro toxicity of airborne (nano)particles to the human respiratory system: from basic to advanced models.
- Author
-
Bessa MJ, Brandão F, Rosário F, Moreira L, Reis AT, Valdiglesias V, Laffon B, Fraga S, and Teixeira JP
- Subjects
- Humans, Dust, Inhalation Exposure adverse effects, Respiratory System, Nanoparticles toxicity
- Abstract
Several studies have been conducted to address the potential adverse health risks attributed to exposure to nanoscale materials. While in vivo studies are fundamental for identifying the relationship between dose and occurrence of adverse effects, in vitro model systems provide important information regarding the mechanism(s) of action at the molecular level. With a special focus on exposure to inhaled (nano)particulate material toxicity assessment, this review provides an overview of the available human respiratory models and exposure systems for in vitro testing, advantages, limitations, and existing investigations using models of different complexity. A brief overview of the human respiratory system, pathway and fate of inhaled (nano)particles is also presented.
- Published
- 2023
- Full Text
- View/download PDF
39. Association of Torquetenovirus Viremia with Physical Frailty and Cognitive Impairment in Three Independent European Cohorts.
- Author
-
Giacconi R, Laffon B, Costa S, Teixeira-Gomes A, Maggi F, Macera L, Spezia PG, Piacenza F, Bürkle A, Moreno-Villanueva M, Bonassi S, Valdiglesias V, Teixeira JP, Dollé MET, Rietman ML, Jansen E, Grune T, Gonos ES, Franceschi C, Capri M, Weinberger B, Sikora E, Stuetz W, Toussaint O, Debacq-Chainiaux F, Hervonen A, Hurme M, Slagboom PE, Schön C, Bernhardt J, Breusing N, Pásaro E, Maseda A, Lorenzo-López L, Millán-Calenti JC, Provinciali M, and Malavolta M
- Subjects
- Female, Aged, Humans, Aged, 80 and over, Viremia complications, Frail Elderly psychology, Geriatric Assessment, Frailty epidemiology, Torque teno virus physiology, Cognitive Dysfunction complications, Cognitive Dysfunction epidemiology
- Abstract
Introduction: Immunosenescence and inflammaging have been implicated in the pathophysiology of frailty. Torquetenovirus (TTV), a single-stranded DNA anellovirus, the major component of the human blood virome, shows an increased replication rate with advancing age. An elevated TTV viremia has been associated with an impaired immune function and an increased risk of mortality in the older population. The objective of this study was to analyze the relation between TTV viremia, physical frailty, and cognitive impairment., Methods: TTV viremia was measured in 1,131 nonfrail, 45 physically frail, and 113 cognitively impaired older adults recruited in the MARK-AGE study (overall mean age 64.7 ± 5.9 years), and then the results were checked in two other independent cohorts from Spain and Portugal, including 126 frail, 252 prefrail, and 141 nonfrail individuals (overall mean age: 77.5 ± 8.3 years)., Results: TTV viremia ≥4log was associated with physical frailty (OR: 4.69; 95% CI: 2.06-10.67, p < 0.0001) and cognitive impairment (OR: 3.49, 95% CI: 2.14-5.69, p < 0.0001) in the MARK-AGE population. The association between TTV DNA load and frailty status was confirmed in the Spanish cohort, while a slight association with cognitive impairment was observed (OR: 1.33; 95% CI: 1.000-1.773), only in the unadjusted model. No association between TTV load and frailty or cognitive impairment was found in the Portuguese sample, although a negative association between TTV viremia and MMSE score was observed in Spanish and Portuguese females., Conclusions: These findings demonstrate an association between TTV viremia and physical frailty, while the association with cognitive impairment was observed only in the younger population from the MARK-AGE study. Further research is necessary to clarify TTV's clinical relevance in the onset and progression of frailty and cognitive decline in older individuals., (© 2023 S. Karger AG, Basel.)
- Published
- 2023
- Full Text
- View/download PDF
40. Suitability of salivary leucocytes to assess DNA repair ability in human biomonitoring studies by the challenge-comet assay.
- Author
-
Fernández-Bertólez N, Lema-Arranz C, Fraga S, Teixeira JP, Pásaro E, Lorenzo-López L, Valdiglesias V, and Laffon B
- Subjects
- Bleomycin, Comet Assay methods, DNA Damage, DNA Repair, Humans, Methyl Methanesulfonate, Ultraviolet Rays, Biological Monitoring, Leukocytes, Mononuclear
- Abstract
The challenge-comet assay is a simple but effective approach that provides a quantitative and functional determination of DNA repair ability, and allows to monitor the kinetics of repair process. Peripheral blood mononuclear cells (PBMC) are the cells most frequently employed in human biomonitoring studies using the challenge-comet assay, but having a validated alternative of non-invasive biomatrix would be highly convenient for certain population groups and circumstances. The objective of this study was to validate the use of salivary leucocytes in the challenge-comet assay. Leucocytes were isolated from saliva samples and challenged (either in fresh or after cryopreservation) with three genotoxic agents acting by different action mechanisms: bleomycin, methyl methanesulfonate, and ultraviolet radiation. Comet assay was performed just after treatment and at other three additional time points, in order to study repair kinetics. The results obtained demonstrated that saliva leucocytes were as suitable as PBMC for assessing DNA damage of different nature that was efficiently repaired over the evaluated time points, even after 5 months of cryopreservation (after a 24 h stimulation with PHA). Furthermore, a new parameter to determine the efficacy of the repair process, independent of the initial amount of damage induced, is proposed, and recommendations to perform the challenge-comet assay with salivary leucocytes depending on the type of DNA repair to be assessed are suggested. Validation studies are needed to verify whether the method is reproducible and results reliable and comparable among laboratories and studies., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
41. Relationship between DNA damage measured by the comet-assay and cognitive function.
- Author
-
Lorenzo-López L, Lema-Arranz C, Fernández-Bertólez N, Costa S, Costa C, Teixeira JP, Pásaro E, Valdiglesias V, and Laffon B
- Subjects
- Animals, Humans, Female, Pregnancy, Comet Assay, Cognition, Genomic Instability, DNA Damage, Cognitive Dysfunction genetics
- Abstract
Recent studies exploring the relationship between DNA damage measured by the comet assay (single-cell gel electrophoresis) and cognitive function in both animal models and humans are reviewed and summarized. This manuscript provides an overview of studies exploring cognitive dysfunction related to DNA damage due to biological ageing process, cancer treatment, adverse environmental or occupational exposures, and prenatal genotoxic exposure. The review confirms the potential of comet assay to further explore the link between DNA damage, as indicative of genomic instability, and cognitive impairment in different research and clinical areas. Analysed studies support, in fact, the significant relationship between DNA damage and cognitive impairment, mainly affecting attention, working memory and executive functions. These cognitive domains are crucial to daily functioning and occupational performance, with important clinical implications. Although evidence support the relationship between DNA damage measured by the comet assay and cognitive function in different settings, further longitudinal research is needed to disentangle the temporal relationship between them over time, and to explore the potential of comet assay-detected DNA lesions to predict response to interventions., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
42. Relationship between structure and cytotoxicity of vanadium and molybdenum complexes with pyridoxal derived ligands.
- Author
-
Mato-López L, Sar-Rañó A, Fernández MR, Díaz-Prado ML, Gil A, Sánchez-González Á, Fernández-Bertólez N, Méndez J, Valdiglesias V, and Avecilla F
- Subjects
- Animals, Ligands, Pyridoxal pharmacology, Zebrafish, Molybdenum chemistry, Molybdenum pharmacology, Vanadium chemistry, Vanadium pharmacology
- Abstract
In this work four vanadium complexes (compounds 1, 2, 3 and 4) and one molybdenum complex (compound 5) with hydrazone ligands derived from pyridoxal were synthesized and characterized. All compounds are mononuclear species, two of them (compounds 3 and 5) are dioxide complexes and the other three (compounds 1, 2 and 4) monoxide complexes. The vanadium atom of the compound 3 is five-coordinated and all the other compounds have a six coordinated environment polyhedron. The poses for the potential intercalation of the compounds 2 and 3 with DNA were obtained by using AutoDock software. Optimizations were also performed at PM6-D3H4 semi-empirical level whereas the study of the nature of the interaction was carried out by means of the Energy Decomposition Analysis and the Non-Covalent Interaction index by using in both cases Density Functional Theory computations. The cytotoxicity in lung cancer cells (A549 cell line) of all the compounds was also evaluated. After 24 h of treatment, vanadium complexes showed high values of IC
50 , between 419.93 ± 22.58 and 685.88 ± 46.55 μM. After 48 h, the results showed that the compound 3 had the lowest IC50 value, 65.32 ± 9.95 μM, and the compound 2 the highest value, 375.28 ± 32.09 μM. The molybdenum complex showed the lowest IC50 value at 48 h (11.22 ± 1.34 μM). The toxicity of the compounds 3, 4 and 5 was tested in vivo, using zebrafish model, and the molybdenum complex showed higher toxic effects than the studied vanadium complexes., (Copyright © 2022. Published by Elsevier Inc.)- Published
- 2022
- Full Text
- View/download PDF
43. From trihalomethanes chronic daily intake through multiple exposure routes to cancer and non-cancer health risk assessment: Evidence from public Portuguese indoor swimming pools facilities using a probabilistic approach.
- Author
-
Costa C, Assunção R, Sequeira D, Esteves F, Valdiglesias V, Laffon B, Teixeira JP, and Madureira J
- Subjects
- Female, Humans, Male, Portugal epidemiology, Risk Assessment, Trihalomethanes analysis, Water Supply, Neoplasms chemically induced, Neoplasms epidemiology, Swimming Pools, Water Pollutants, Chemical analysis
- Abstract
This study aimed to estimate chronic daily intake (CDI) and to predict the attributable lifetime cancer risk (LCR) and hazard index (HI) from concurrent exposure to four trihalomethanes (THMs; chloroform, bromodichloromethane, dibromochloromethane and bromoform), via multiple exposure routes (oral ingestion, dermal contact and inhalation), among 238 non-competitive attendees of 10 Portuguese public indoor swimming pools (SPs), using a probabilistic approach based on Monte Carlo simulations. Exposure parameters of study participants were collected via questionnaires and THMs levels in SPs water were determined according the respective normative standards. The CDI for total THMs calculated for male and female participants considering all routes was 7.52 and 8.97 mg/kg/day, respectively. SP attendees presented higher CDI through inhalation than via the other two exposure routes, and chloroform was the compound contributing the most to total THMs CDI. The risk analysis indicated that the total LCR and HI from the targeted THMs were higher than the negligible risk levels (1 × 10
-6 and 1, respectively) in the scenarios examined (central tendency exposure and reasonable maximum exposure), and the health risk for females was slightly higher than for males. This study suggests that there are possible adverse health risks, thus, to protect pool attendees, adequate mitigation measures, and comprehensive regulatory guidelines on individual THMs concentrations are needed., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2021 Elsevier B.V. All rights reserved.)- Published
- 2022
- Full Text
- View/download PDF
44. A pooled analysis of molecular epidemiological studies on modulation of DNA repair by host factors.
- Author
-
Opattova A, Langie SAS, Milic M, Collins A, Brevik A, Coskun E, Dusinska M, Gaivão I, Kadioglu E, Laffon B, Marcos R, Pastor S, Slyskova J, Smolkova B, Szilágyi Z, Valdiglesias V, Vodicka P, Volkovova K, Bonassi S, and Godschalk RWL
- Subjects
- Comet Assay, DNA-Formamidopyrimidine Glycosylase, Epidemiologic Studies, Female, Humans, Male, Middle Aged, DNA Damage, DNA Repair genetics
- Abstract
Levels of DNA damage represent the dynamics between damage formation and removal. Therefore, to better interpret human biomonitoring studies with DNA damage endpoints, an individual's ability to recognize and properly remove DNA damage should be characterized. Relatively few studies have included DNA repair as a biomarker and therefore, assembling and analyzing a pooled database of studies with data on base excision repair (BER) was one of the goals of hCOMET (EU-COST CA15132). A group of approximately 1911 individuals, was gathered from 8 laboratories which run population studies with the comet-based in vitro DNA repair assay. BER incision activity data were normalized and subsequently correlated with various host factors. BER was found to be significantly higher in women. Although it is generally accepted that age is inversely related to DNA repair, no overall effect of age was found, but sex differences were most pronounced in the oldest quartile (>61 years). No effect of smoking or occupational exposures was found. A body mass index (BMI) above 25 kg/m
2 was related to higher levels of BER. However, when BMI exceeded 35 kg/m2 , repair incision activity was significantly lower. Finally, higher BER incision activity was related to lower levels of DNA damage detected by the comet assay in combination with formamidopyrimidine DNA glycosylase (Fpg), which is in line with the fact that oxidatively damaged DNA is repaired by BER. These data indicate that BER plays a role in modulating the steady-state level of DNA damage that is detected in molecular epidemiological studies and should therefore be considered as a parallel endpoint in future studies., (Copyright © 2022. Published by Elsevier B.V.)- Published
- 2022
- Full Text
- View/download PDF
45. Cytotoxicity and Genotoxicity of Nanomaterials.
- Author
-
Valdiglesias V
- Abstract
Nanomaterials (NMs) are of significant relevance due to their unique physicochemical properties, which have been extensively exploited for widespread applications in human healthcare and consumer goods, such as cosmetics and textiles [...].
- Published
- 2022
- Full Text
- View/download PDF
46. Toxicological Aspects of Iron Oxide Nanoparticles.
- Author
-
Fernández-Bertólez N, Costa C, Brandão F, Teixeira JP, Pásaro E, Valdiglesias V, and Laffon B
- Subjects
- Drug Delivery Systems adverse effects, Ferric Compounds chemistry, Ferric Compounds therapeutic use, Ferric Compounds toxicity, Magnetic Iron Oxide Nanoparticles, Magnetics, Nanomedicine, Nanoparticles chemistry, Nanoparticles toxicity
- Abstract
Iron oxide nanoparticles (ION), with unique magnetic properties, have attracted huge scientific attention for a wide variety of uses, mostly in the biomedical field, due to their high biocompatibility, ability to cross biological membranes, appropriate surface architecture and easy conjugation with targeting ligands. Their current applications include diagnostic imaging, cell labelling, site-directed drug delivery and anticancer hyperthermia therapy. The ION surface may be modified by coating with different materials, aiming to stabilize the nanoparticles in different environments, to allow biomolecule binding favouring surface attachments with several molecules, and to prolong the recognition time by the immune system. Although the potential benefits of ION are considerable, and more and more ION are being manufactured to meet the demands of the rapidly proliferating field of nanomedicine, there is an urgent need to define their toxicological profile in order to avoid any potential health risks associated with their exposure and to reach optimal benefits of their use. The purpose of this chapter is to de-scribe the current knowledge on the ION toxicological features, addressing their structure and physicochemical characteristics, main exposure pathways and toxicokinetic aspects, interaction with cells, and their toxic effects, with special attention to those at the cellular and molecular level., (© 2022. The Author(s), under exclusive license to Springer Nature Switzerland AG.)
- Published
- 2022
- Full Text
- View/download PDF
47. Exploring Early Detection of Frailty Syndrome in Older Adults: Evaluation of Oxi-Immune Markers, Clinical Parameters and Modifiable Risk Factors.
- Author
-
Teixeira-Gomes A, Laffon B, Valdiglesias V, Gostner JM, Felder T, Costa C, Madureira J, Fuchs D, Teixeira JP, and Costa S
- Abstract
Ageing is accompanied with a decline in several physiological systems. Frailty is an age-related syndrome correlated to the loss of homeostasis and increased vulnerability to stressors, which is associated with increase in the risk of disability, comorbidity, hospitalisation, and death in older adults. The aim of this study was to understand the relationship between frailty syndrome, immune activation, and oxidative stress. Serum concentrations of vitamins A and E were also evaluated, as well as inflammatory biomarkers (CRP and IL-6) and oxidative DNA levels. A group of Portuguese older adults (≥65 years old) was engaged in this study and classified according to Fried's frailty phenotype. Significant increases in the inflammatory mediators (CRP and IL-6), neopterin levels, kynurenine to tryptophan ratio (Kyn/Trp), and phenylalanine to tyrosine ratio (Phe/Tyr), and significant decreases in Trp and Tyr concentrations were observed in the presence of frailty. IL-6, neopterin, and Kyn/Trp showed potential as predictable biomarkers of frailty syndrome. Several clinical parameters such as nutrition, dependency scales, and polypharmacy were related to frailty and, consequently, may influence the associations observed. Results obtained show a progressive immune activation and production of pro-inflammatory molecules in the presence of frailty, agreeing with the inflammageing model. Future research should include different dimensions of frailty, including psychological, social, biological, and environmental factors.
- Published
- 2021
- Full Text
- View/download PDF
48. Author Correction: DNA damage in circulating leukocytes measured with the comet assay may predict the risk of death.
- Author
-
Bonassi S, Ceppi M, Møller P, Azqueta A, Milić M, Neri M, Brunborg G, Godschalk R, Koppen G, Langie SAS, Teixeira JP, Bruzzone M, Da Silva J, Benedetti D, Cavallo D, Ursini CL, Giovannelli L, Moretti S, Riso P, Del Bo' C, Russo P, Dobrzyńska M, Goroshinskaya IA, Surikova EI, Staruchova M, Barančokova M, Volkovova K, Kažimirova A, Smolkova B, Laffon B, Valdiglesias V, Pastor S, Marcos R, Hernández A, Gajski G, Spremo-Potparević B, Živković L, Boutet-Robinet E, Perdry H, Lebailly P, Perez CL, Basaran N, Nemeth Z, Safar A, Dusinska M, and Collins A
- Published
- 2021
- Full Text
- View/download PDF
49. DNA damage in circulating leukocytes measured with the comet assay may predict the risk of death.
- Author
-
Bonassi S, Ceppi M, Møller P, Azqueta A, Milić M, Neri M, Brunborg G, Godschalk R, Koppen G, Langie SAS, Teixeira JP, Bruzzone M, Da Silva J, Benedetti D, Cavallo D, Ursini CL, Giovannelli L, Moretti S, Riso P, Del Bo' C, Russo P, Dobrzyńska M, Goroshinskaya IA, Surikova EI, Staruchova M, Barančokova M, Volkovova K, Kažimirova A, Smolkova B, Laffon B, Valdiglesias V, Pastor S, Marcos R, Hernández A, Gajski G, Spremo-Potparević B, Živković L, Boutet-Robinet E, Perdry H, Lebailly P, Perez CL, Basaran N, Nemeth Z, Safar A, Dusinska M, and Collins A
- Subjects
- Comet Assay, Humans, Kaplan-Meier Estimate, Leukocytes pathology, Neoplasms mortality, Proportional Hazards Models, Cell-Free Nucleic Acids genetics, DNA Damage genetics, Neoplasms genetics
- Abstract
The comet assay or single cell gel electrophoresis, is the most common method used to measure strand breaks and a variety of other DNA lesions in human populations. To estimate the risk of overall mortality, mortality by cause, and cancer incidence associated to DNA damage, a cohort of 2,403 healthy individuals (25,978 person-years) screened in 16 laboratories using the comet assay between 1996 and 2016 was followed-up. Kaplan-Meier analysis indicated a worse overall survival in the medium and high tertile of DNA damage (p < 0.001). The effect of DNA damage on survival was modelled according to Cox proportional hazard regression model. The adjusted hazard ratio (HR) was 1.42 (1.06-1.90) for overall mortality, and 1.94 (1.04-3.59) for diseases of the circulatory system in subjects with the highest tertile of DNA damage. The findings of this study provide epidemiological evidence encouraging the implementation of the comet assay in preventive strategies for non-communicable diseases., (© 2021. The Author(s).)
- Published
- 2021
- Full Text
- View/download PDF
50. Suitability of the In Vitro Cytokinesis-Block Micronucleus Test for Genotoxicity Assessment of TiO 2 Nanoparticles on SH-SY5Y Cells.
- Author
-
Fernández-Bertólez N, Brandão F, Costa C, Pásaro E, Teixeira JP, Laffon B, and Valdiglesias V
- Subjects
- Cell Line, Tumor, Cytochalasin B pharmacology, Dose-Response Relationship, Drug, Humans, Titanium pharmacology, Cytokinesis drug effects, Micronuclei, Chromosome-Defective, Nanoparticles adverse effects, Titanium adverse effects
- Abstract
Standard toxicity tests might not be fully adequate for evaluating nanomaterials since their unique features are also responsible for unexpected interactions. The in vitro cytokinesis-block micronucleus (CBMN) test is recommended for genotoxicity testing, but cytochalasin-B (Cyt-B) may interfere with nanoparticles (NP), leading to inaccurate results. Our objective was to determine whether Cyt-B could interfere with MN induction by TiO
2 NP in human SH-SY5Y cells, as assessed by CBMN test. Cells were treated for 6 or 24 h, according to three treatment options: co-treatment with Cyt-B, post-treatment, and delayed co-treatment. Influence of Cyt-B on TiO2 NP cellular uptake and MN induction as evaluated by flow cytometry (FCMN) were also assessed. TiO2 NP were significantly internalized by cells, both in the absence and presence of Cyt-B, indicating that this chemical does not interfere with NP uptake. Dose-dependent increases in MN rates were observed in CBMN test after co-treatment. However, FCMN assay only showed a positive response when Cyt-B was added simultaneously with TiO2 NP, suggesting that Cyt-B might alter CBMN assay results. No differences were observed in the comparisons between the treatment options assessed, suggesting they are not adequate alternatives to avoid Cyt-B interference in the specific conditions tested.- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.